表紙
市場調查報告書

全球人類胚胎幹細胞(hESC)研究市場

Human Embryonic Stem Cell (hESC) Research

出版商 Global Industry Analysts, Inc. 商品編碼 248880
出版日期 內容資訊 英文 95 Pages
商品交期: 最快1-2個工作天內
價格
全球人類胚胎幹細胞(hESC)研究市場 Human Embryonic Stem Cell (hESC) Research
出版日期: 2020年05月01日內容資訊: 英文 95 Pages
簡介

本報告提供全球人類胚胎幹細胞(hESC)研究市場相關調查,提供市場概要與今後預測,各地區趨勢,及加入此市場的主要企業簡介。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 幹細胞研究
    • 人類胚胎幹細胞(hESC)
    • ES細胞
    • 市場預測
    • ES細胞研究開發的時間軸
    • 阻礙人類胚胎幹細胞(hESC)研究發展的問題
    • 考察確保hESC成長的最佳轉化途徑
    • 倫理問題和技術性門檻阻礙 市場其他
  • 法律制度
    • 概要
    • 全球主要各國的人類胚胎幹細胞(hESC)相關法規
    • 智慧財產權
    • WARF無法在歐洲獲得專利
    • 專利制度的多樣性構成巨大挑戰
    • 國際鴻溝專利案例研究
  • 人類胚胎幹細胞(hESC)的用途和臨床實驗
    • 藥物檢驗
    • 臨床應用
    • 人類胚胎幹細胞(hESC)有助於心肌細胞心臟毒性的鑑定 其他
  • 競爭環境
    • 概要
    • 從事hESC和iPSC基礎藥物及產品開發的全球主要企業
    • Astellas Institute of Regenerative Medicine
    • Asterias Biotherapeutics, Inc.
    • BD Biosciences
    • Cell Cure Neurosciences Ltd.
    • Cellular Dynamics International
    • GE Healthcare
    • MilliporeSigma
    • PerkinElmer, Inc.
    • Reliance Life Sciences Ltd.
    • Research & Diagnostics Systems, Inc.
    • SABiosciences Corp.
    • STEMCELL Technologies, Inc.
    • Stemina Biomarker Discovery, Inc.
    • TaKaRa BIO株式會社
    • TATAA Biocenter AB
    • Thermo Fisher Scientific, Inc
    • UK Stem Cell Bank
    • ViaCyte, Inc.
    • Vitrolife AB
  • 各地區市場概要
    • 美國
    • 歐洲
    • 亞太地區
  • 近幾年的產業活動
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6831

Amid the COVID-19 crisis and the looming economic recession, the Human Embryonic Stem Cell (hESC) Research market worldwide will grow by a projected US$407.9 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 7.7%. Regenerative Medicine, one of the segments analyzed and sized in this study, is forecast to grow at over 7.8% and reach a market size of US$717.5 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Regenerative Medicine market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 7.7% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$16.4 Million to the region's size over the next 7 to 8 years. In addition, over US$16.2 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Regenerative Medicine segment will reach a market size of US$48.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Human Embryonic Stem Cell (hESC) Research market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 6.8% over the next couple of years and add approximately US$58.8 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Human Embryonic Stem Cell (hESC) Research market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Astellas Institute of Regenerative Medicine; Asterias Biotherapeutics, Inc.; BD Biosciences; Cell Cure Neurosciences Ltd.; Cellular Dynamics International; GE Healthcare; PerkinElmer, Inc.; Reliance Life Sciences Ltd.; Research & Diagnostics Systems, Inc.; STEMCELL Technologies, Inc.; Stemina Biomarker Discovery, Inc.; Takara Bio, Inc.; TATAA Biocenter AB; Thermo Fischer Scientific Inc.; UK Stem Cell Bank; ViaCyte, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Stem Cells Research: A Sunrise Sector in Biotechnology Arena
  • Human Embryonic Stem Cells - An Introduction
  • Embryonic Stem Cells - Sources and Cell Culture
  • Comparison on Adult and Embryonic Stem Cells
  • Advantages and Drawbacks of Various Stem Cells
  • Recent Market Activity
  • Human Embryonic Stem Cells - The Market Perspective
  • Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
  • Teratomas - No Longer an Impediment to Stem Cell Therapy Development
  • Human Embryonic and Induced Pluripotent Stem Cell Research Trends
  • Human Embryonic Stem Cell Research: Key Statistical Highlights
  • Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
  • Haploid Human Embryonic Stem Cell Line: The New Frontier
  • Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
  • Global Competitor Market Shares
  • Human Embryonic Stem Cell (hESC) Research Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neurosciences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)

3. MARKET TRENDS & DRIVERS

  • Issues Hindering Development of hESC Research
  • Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
  • Ethical Issues and Technical Hurdles Bog Down hESC Research

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Human Embryonic Stem Cell (hESC) Research Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Human Embryonic Stem Cell (hESC) Research Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Regenerative Medicine (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 4: Regenerative Medicine (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Stem Cell Biology Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 6: Stem Cell Biology Research (Application) Market Share Shift across Key Geographies: 2020 VS 2027
  • TABLE 7: Tissue Engineering (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 8: Tissue Engineering (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 9: Toxicology Testing (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 10: Toxicology Testing (Application) Share Breakdown Review by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Human Embryonic Stem Cell (hESC) Research Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 11: United States Human Embryonic Stem Cell (hESC) Research Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 12: Human Embryonic Stem Cell (hESC) Research Market Share Breakdown in the United States by Application: 2020 VS 2027
  • CANADA
    • TABLE 13: Canadian Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 14: Canadian Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • JAPAN
    • TABLE 15: Japanese Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 16: Human Embryonic Stem Cell (hESC) Research Market Share Shift in Japan by Application: 2020 VS 2027
  • CHINA
    • TABLE 17: Chinese Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 18: Chinese Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Human Embryonic Stem Cell (hESC) Research Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 19: European Human Embryonic Stem Cell (hESC) Research Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 20: European Human Embryonic Stem Cell (hESC) Research Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 21: European Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 22: European Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • FRANCE
    • TABLE 23: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
    • TABLE 24: French Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • GERMANY
    • TABLE 25: Human Embryonic Stem Cell (hESC) Research Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 26: Human Embryonic Stem Cell (hESC) Research Market Share Distribution in Germany by Application: 2020 VS 2027
  • ITALY
    • TABLE 27: Italian Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 28: Italian Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 29: United Kingdom Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 30: Human Embryonic Stem Cell (hESC) Research Market Share Shift in the United Kingdom by Application: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 31: Rest of Europe Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 32: Rest of Europe Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 33: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
    • TABLE 34: Asia-Pacific Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • REST OF WORLD
    • TABLE 35: Rest of World Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 36: Rest of World Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 25